Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/SENSORION-21685779/attualita/Sensorion-SA-aggiorna-sullo-studio-di-fase-2-SENS-401-nella-perdita-improvvisa-dell-udito-neurosenso-37565718/?utm_source=whatsapp&utm_medium=social&utm_campaign=share